Literature DB >> 11823956

Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors.

Nicola Petrosillo1, Pierluigi Viale, Emanuele Nicastri, Claudio Arici, Enrico Bombana, Alberto Casella, Francesco Cristini, Michele De Gennaro, Ferdinando Dodi, Andrea Gabbuti, Gianni Gattuso, Laura Irato, Paolo Maggi, Federico Pallavicini, Angelo Pan, Mario Pantaleoni, Giuseppe Ippolito.   

Abstract

To assess the incidence of nosocomial bloodstream infections (NBSIs) in human immunodeficiency virus (HIV)-infected patients, and to analyze the main associated risk factors, we performed a 1-year multicenter prospective study of patients with advanced HIV infection who were consecutively admitted to 17 Italian infectious diseases wards. As of May 1999, a total of 65 NBSIs (4.7%) occurred in 1379 admissions, for an incidence of 2.45 NBSIs per 1000 patient-days. Twenty-nine NBSIs were catheter-related bloodstream infections, with a rate of 9.6 central venous catheter-associated infections per 1000 device-days. Multivariate analysis indicated that variables independently associated with NBSIs included active injection drug use, a Karnofsky Performance Status score of <40, presence of a central venous catheter, and length of hospital stay. Mortality rates were 24.6% and 7.2% among patients with and without NBSIs, respectively (P<.00001). In the era of highly active antiretroviral therapy, NBSIs continue to occur frequently and remain severe and life-threatening manifestations.

Entities:  

Mesh:

Year:  2002        PMID: 11823956     DOI: 10.1086/338813

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Acquisition of resistant microorganisms and infections in HIV-infected patients admitted to the ICU.

Authors:  N Cobos-Trigueros; M Rinaudo; M Solé; P Castro; J Pumarol; C Hernández; S Fernández; J M Nicolás; J Mallolas; J Vila; L Morata; J M Gatell; A Soriano; J Mensa; J A Martínez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-23       Impact factor: 3.267

Review 3.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

Review 4.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Risk of healthcare associated infections in HIV positive patients.

Authors:  Mohammed Mitha; E Yoko Furuya; Elaine Larson
Journal:  J Infect Prev       Date:  2014-11-01

Review 6.  Bloodstream infections in HIV-infected patients.

Authors:  Lucia Taramasso; Paola Tatarelli; Antonio Di Biagio
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

7.  Risk Factors and Temporal Trends of Hospital-Acquired Infections (HAIs) Among HIV Positive Patients in Urban New York City Hospitals: 2006 to 2014.

Authors:  Christophe T Tchakoute; Jianfang Liu; Bevin Cohen; Elaine Larson
Journal:  Rev Recent Clin Trials       Date:  2017

8.  Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users.

Authors:  M Miller; C Cespedes; P Vavagiakis; R S Klein; F D Lowy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-18       Impact factor: 3.267

9.  Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality.

Authors:  M Ortega; M Almela; A Soriano; F Marco; J A Martínez; A Muñoz; G Peñarroja; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

10.  Candidemia in Finland, 1995-1999.

Authors:  Eira Poikonen; Outi Lyytikäinen; Veli-Jukka Anttila; Petri Ruutu
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.